다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

SNY

Sanofi (SNY)

Sanofi

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/19	02:23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
2024/11/15	14:59	GlobeNewswire Inc.	Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)	NASDAQ:SNY	Sanofi
2024/11/06	15:00	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis	NASDAQ:SNY	Sanofi
2024/10/29	06:56	PR Newswire (Canada)	L'immunisation par Beyfortus® pour protéger les nourrissons contre le VRS a commencé	NASDAQ:SNY	Sanofi
2024/10/29	06:54	PR Newswire (Canada)	Beyfortus® immunization to protect infants from RSV has begun	NASDAQ:SNY	Sanofi
2024/10/25	19:05	IH Market News	Capri Shares Crash 45% After Merger Block; Coursera Falls 18% on Lower Revenue Forecast	NASDAQ:SNY	Sanofi
2024/10/21	18:47	IH Market News	Spirit’s Stock Surges 56% on Refinancing; Starboard Invests in Kenvue; Cigna-Humana Merger Back in Negotiations	NASDAQ:SNY	Sanofi
2024/10/17	15:35	Business Wire	Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines	NASDAQ:SNY	Sanofi
2024/10/17	15:35	Business Wire	Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération	NASDAQ:SNY	Sanofi
2024/10/17	01:26	PR Newswire (US)	FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals	NASDAQ:SNY	Sanofi
2024/10/16	19:00	PR Newswire (US)	Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies	NASDAQ:SNY	Sanofi
2024/10/11	19:31	IH Market News	BP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and More	NASDAQ:SNY	Sanofi
2024/09/27	22:35	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD	NASDAQ:SNY	Sanofi
2024/09/27	20:00	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)	NASDAQ:SNY	Sanofi
2024/09/25	03:51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
2024/09/23	19:32	IH Market News	Apollo Eyes $5 Billion Investment in Intel; TSMC and Samsung Explore UAE Chip Projects, and More	NASDAQ:SNY	Sanofi
2024/09/20	20:45	GlobeNewswire Inc.	Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old	NASDAQ:SNY	Sanofi
2024/09/16	21:00	PR Newswire (US)	Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA	NASDAQ:SNY	Sanofi
2024/09/14	01:15	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)	NASDAQ:SNY	Sanofi
2024/09/12	15:37	Business Wire	Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers rares	NASDAQ:SNY	Sanofi
2024/09/12	15:37	Business Wire	Sanofi, RadioMedix, and Orano Med Announce Licensing Agreement on Next-Generation Radioligand Medicine for Rare Cancers	NASDAQ:SNY	Sanofi
2024/08/13	22:06	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SNY	Sanofi
2024/08/13	19:30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SNY	Sanofi
2024/08/13	19:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
2024/07/27	01:08	PR Newswire (Canada)	Le vaccin FluzoneMD Haute Dose Quadrivalent demeure le vaccin préférentiellement recommandé pour protéger les adultes de 65 ans et plus contre la grippe	NASDAQ:SNY	Sanofi
2024/07/27	00:17	PR Newswire (Canada)	Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza	NASDAQ:SNY	Sanofi
2024/07/25	19:19	IH Market News	Earnings Updates: Ford Shares Fall 13% on EPS Miss, Stellantis Down 6%, Viking Therapeutics Up 20%, Unilever Up 5%	NASDAQ:SNY	Sanofi
2024/07/11	05:10	PR Newswire (US)	Sanofi ships U.S. influenza vaccines for the 2024/25 season	NASDAQ:SNY	Sanofi
2024/07/09	19:54	IH Market News	BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News	NASDAQ:SNY	Sanofi
2024/06/27	06:30	GlobeNewswire Inc.	Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine	NASDAQ:SNY	Sanofi

검색 관련기사 보기:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 다음 >>

Verizon Communications

American Express

Gold vs US Dollar

Bank of America

Deutsche Telekom (QX)

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관